Ecolex Logo
El portal del
derecho ambiental
Resultados de la búsqueda » Legislación

Law on medicine and drugs.

País/Territorio
Mongolia
Tipo de documento
Legislación
Fecha
2010 (2015)
Fuente
FAO, FAOLEX
Materia
Ganado
Palabra clave
Legislación básica Sanidad animal Medicamentos Biotecnología Conocimientos tradicionales/ conocimiento indígena Registro Autorización/permiso Certificación Comercio interior Comercio internacional
Área geográphica
Asia, Asia y Pacifico, Asia Oriental, Naciones en desarrollo sin litoral
Entry into force notes
This Law enters into force on 1 July 2011.
Resumen

This Law shall be applicable to medicine and veterinary, including traditional medicines and drugs, medical equipment and bioactive products, regulating manufacturing, import, export, storage, trade, distribution and control thereof. The National Drug Policy shall be directed to provide medical organizations, veterinary hospitals and population with guaranteed registered high quality drugs. It establishes plenary powers of the Council on Animal Husbandry in the field of animal health and veterinary drugs. Manufacturing, import, export, distribution and control of drugs shall be subject to mandatory licensing. Drugs shall be subject to mandatory certification. Veterinarians shall provide services to owners of livestock using exclusively medical equipment and veterinary drugs supplied by registered licensed drug supplying organizations. Veterinary drugs shall be packaged and labelled in accordance with the established modalities. New veterinary drugs must pass mandatory pre-clinical and clinical testing and registration. Information on drugs shall be aimed at proper and correct application thereof. This Law consists of IX Chapters divided into 30 Articles. Chapter I lays down general provisions. Chapter II regards regulation of drugs, registration thereof and healthcare activity. Chapter III regards protection of health and manufacturing of drugs and medical equipment. Chapter IV regards import and export of drugs and medical equipment. Chapter V regards risk management. Chapter VI regards new pharmaceutical products. Chapter VII regards manufacturing and trade of medicinal products and bioactive products. Chapter VIII regards information and advertisement of drugs. Chapter IX contains additional provisions.

Texto completo
Mongol
Página web
www.legalinfo.mn